이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Hubei Zhenhua ChemicalLtd 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Yu Sheng Ke

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	0.6%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

Is Hubei Zhenhua ChemicalLtd (SHSE:603067) A Risky Investment?

May 28

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) Surges 31% Yet Its Low P/E Is No Reason For Excitement

Apr 30

CEO

Yu Sheng Ke (61 yo)

no data

테뉴어

CN¥1,518,800

보상

Mr. Yu Sheng Ke serves as General Manager and Director at Hubei Zhenhua Chemical Co., Ltd. Mr. Ke is an Engineer.

Hubei Zhenhua ChemicalLtd 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Hubei Zhenhua Chemical Co.,Ltd., Annual General Meeting, Apr 30, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Hubei Zhenhua Chemical Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024

Is Hubei Zhenhua ChemicalLtd (SHSE:603067) A Risky Investment?

Investor sentiment improves as stock rises 18%

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) Surges 31% Yet Its Low P/E Is No Reason For Excitement

First quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.20 in 1Q 2023)

Full year 2023 earnings: EPS misses analyst expectations

Hubei Zhenhua Chemical Co.,Ltd., Annual General Meeting, Apr 30, 2024

Hubei Zhenhua Chemical Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) announces an Equity Buyback for CNY 80 million worth of its shares.

Investor sentiment deteriorates as stock falls 17%

Hubei Zhenhua Chemical Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 10, 2024

Consensus EPS estimates fall by 11%

Third quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.16 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.28 in 2Q 2022)

Hubei Zhenhua Chemical Co.,Ltd. to Report First Half, 2023 Results on Aug 28, 2023

First quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.20 in 1Q 2022)

Price target increased to CN¥26.54

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.18 in 3Q 2021)

Price target increased to CN¥26.54

Second quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.23 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.11 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.12 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.07 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.35 (vs CN¥0.32 in FY 2019)

Hubei Zhenhua Chemical Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day high: CN¥7.54

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) completed the acquisition of Chongqing Minfeng Chemical Co., Ltd. from Chongqing Chemical & Pharmaceutical Holding (Group) Company.

New 90-day low: CN¥6.37

New 90-day low: CN¥6.49

New 90-day high: CN¥7.60

Third quarter earnings released

Hubei Zhenhua Chemical Co.,Ltd. (SHSE:603067) signed an intention agreement to acquire Chongqing Minfeng Chemical Co., Ltd. from Chongqing Chemical & Pharmaceutical Holding (Group) Company for approximately CNY 520 million.

First half earnings released

Hubei Zhenhua Chemical Co.,Ltd. announced a financing transaction

New 90-day high - CN¥8.47

Hubei Zhenhua Chemical Co.,Ltd. to Report First Half, 2020 Results on Aug 21, 2020

CEO

테뉴어

보상